NVIDIA-backed startups develop AI-powered breast cancer screening platform
A new AI-powered breast cancer screening platform is commercially available in several US states, aiming to address the diagnosis gap.
- The breast cancer diagnosis gap is significant, with millions of women not undergoing recommended annual screenings.
- The ATUSA platform, developed by iSono Health, takes only two minutes per breast to capture a standardized volume, compared to up to 45 minutes for handheld ultrasound.
- The ATUSA platform is commercially available in several US states and new sites are being added regularly.
- The development of AI-powered breast cancer screening platforms like ATUSA has the potential to transform the way breast cancer is diagnosed and treated.
- The development of AI-powered breast cancer screening platforms like ATUSA has the potential to significantly improve breast cancer diagnosis and treatment outcomes.
The breast cancer diagnosis gap is significant, with millions of women not undergoing recommended annual screenings. According to the NVIDIA Blog, tens of thousands of women are not receiving the necessary care. This gap is attributed to various factors, including lack of access to healthcare facilities and shortage of skilled healthcare professionals.
AI-powered breast cancer screening platform
The ATUSA platform, developed by iSono Health, takes only two minutes per breast to capture a standardized volume, compared to up to 45 minutes for handheld ultrasound. This reduction in time allows for more efficient and accurate scans. The AI-powered platform uses over 1.5 million ultrasound frames for image acquisition, enabling 3D scan creation. The platform's ability to capture high-quality images in a shorter amount of time is a significant breakthrough. As "getting the scan closer to the patient is the first breakthrough." (NVIDIA Blog), the ATUSA platform has the potential to significantly improve breast cancer diagnosis and treatment outcomes.
Commercial availability and expansion
The ATUSA platform is commercially available in several US states and new sites are being added regularly. This expansion will help address the diagnosis gap by providing more women with access to this technology.
Future prospects and implications
The development of AI-powered breast cancer screening platforms like ATUSA has the potential to transform the way breast cancer is diagnosed and treated. With its ability to capture high-quality images in a shorter amount of time, the ATUSA platform has the potential to improve breast cancer diagnosis and treatment outcomes. Furthermore, the platform's commercial availability and expansion will help address the diagnosis gap and provide more women with access to this technology.
Conclusion
The development of AI-powered breast cancer screening platforms like ATUSA has the potential to significantly improve breast cancer diagnosis and treatment outcomes. With its ability to capture high-quality images in a shorter amount of time, the ATUSA platform has the potential to transform the way breast cancer is diagnosed and treated. tags: breast cancer, AI, healthcare
Sources
Related stories
Gen AI Video Startup Runway Raises $315M Led By General Atlantic At $5.3B Valuation - Crunchbase News
Runway , an AI research and technology startup, said Tuesday that it has raised $315 million in a Series E round of funding. General Atlantic led the financing, which included participation from Nvidia , Adobe Ventures , AMD Ventures , Fidelity Management & Research Co.
NVIDIA Rubin Platform, Open Models, Autonomous Driving: NVIDIA Presents Blueprint for the Future at CES
Editor’s note: The name of NVIDIA DRIVE Hyperion was changed to NVIDIA Hyperion in September 2026. All references to the name have been updated in this blog.
The Nvidia Shield TV Is 7 Years Old. It Just Got a $100 Price Hike
The era of generative AI has upended technology supply chains, and there is one ironclad rule in 2026: If it has memory or storage, it’s getting more expensive. Even devices with years-old tech inside are still apparently subject to that unwritten rule.
Productive, Durable, Fungible: How NVIDIA AI Factories Maximize Return on Investment
AI factories are built by the megawatt, even by the gigawatt. Each megawatt factory costs roughly $60 million, and AI factory operators will only commit capital on that scale with a clear view of the return on investment.
Deploying an HSTU Generative Recommender with NVIDIA Dynamo-Triton
NVIDIA Technical Blog Deploying an HSTU Generative Recommender with NVIDIA Dynamo-Triton By Junyi Qiu , Shijie Liu , J Wyman and Mudit Aggarwal Generative recommender systems reformulate personalization as sequence modeling over user behavior, and NVIDIA recsys-examples now.
Tracing Agent Harness Behavior with NVIDIA NeMo Relay
Tracing Agent Harness Behavior with NVIDIA NeMo Relay | NVIDIA Technical Blog Tracing Agent Harness Behavior with NVIDIA NeMo Relay Learn how to use execution traces to understand agent behavior and determine whether harness changes improve task outcomes.
Sakeena Fiza Helps NVIDIA Hardware Succeed at Scale
When Sakeena Fiza describes her work as a validation engineer at NVIDIA, she does so in terms more befitting a detective story than a world-class engineering lab. “Validation engineers look in the shadows and shine a light into every corner,” Fiza said.
AI Weekly Issue #525: Nvidia may buy into Perplexity above $30B before Wednesday's earnings
The Information reports that Nvidia is discussing an equity investment in Perplexity at a valuation above $30 billion.